Genetic Determinants of Aspergillus host-pathogen interactions
曲霉菌宿主-病原体相互作用的遗传决定因素
基本信息
- 批准号:10724816
- 负责人:
- 金额:$ 23.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-23 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAllergic Bronchopulmonary AspergillosisAnabolismAspergillosisAspergillusAspergillus fumigatusAsthmaAutomobile DrivingCaspaseCell LineChIP-seqChronicClinicalCoculture TechniquesComplexCystic FibrosisDevelopmentFungal ComponentsFutureGene DeletionGene Expression ProfileGene Expression ProfilingGenetic DeterminismGenetic EpistasisGenetic TranscriptionGoalsHumanImmune responseImmunityImmunocompetentImmunocompromised HostIn VitroIndividualInfectionInflammasomeInflammationInflammatory ResponseInterleukin-1 betaLibrariesMacrophageMasksMeasuresMediatingMolecularMorbidity - disease rateOrganismPathogen detectionPathogenicityPathway interactionsPatientsPatternPeripheral Blood Mononuclear CellPhagocytosisProcessProtein KinaseProteinsRegulationResearchResearch DesignRoleScreening ResultSeveritiesSignal TransductionStimulusStress Response SignalingSyndromeTissue-Specific Gene ExpressionVirulenceWorkbiological adaptation to stresschronic infectiondiagnostic criteriafungusgene complementationimmunological statusimmunopathologyimproved outcomein vivomolecular assembly/self assemblymonocytemortalitymouse modelmutantnew therapeutic targetnovelnovel therapeutic interventionpathogenpathogenic fungusprotein-histidine kinaserespiratoryresponsesensor histidine kinasetherapeutic targettooltranscription factortranscriptome sequencing
项目摘要
The long-term goal of our work is to reduce the morbidity and mortality associated with Aspergillus infections by
improving outcomes of host-pathogen interactions. Aspergillus fumigatus is the major airborne fungal pathogen
and is responsible for a range of clinical syndromes, the severity of which is dependent on host immune status.
Invasive pulmonary aspergillosis and disseminated infections can occur in severely immunocompromised hosts
and are often associated with mortality rates of up to 90%. In immune competent hosts, A. fumigatus colonization
can lead to chronic pulmonary aspergillosis (CPA), a clinical manifestation with recently defined diagnostic
criteria that impacts upwards of 1.6 million individuals per year. Many individuals with CPA have underlying
respiratory conditions, such as asthma or cystic fibrosis, that are further exacerbated by the presence of the
fungus. Although multiple Pathogen-Associated Molecular Patterns (PAMPs) driving host recognition and
response are known, uncovering novel fungal molecular pathways that could serve as therapeutic targets to
enhance or mask PAMP display and/or biosynthesis could prove useful therapeutic targets to modulate host
response for improved outcomes. To address this, we utilized activation of the inflammasome, a multiprotein
intracellular complex that detects pathogenic organisms to initiate inflammatory responses, as a tool to uncover
Aspergillus mutants with altered abilities to activate host response. We have completed a preliminary screen to
measure IL-1β secretion from a macrophage differentiated human monocyte cell line employing an A. fumigatus
protein kinase disruption library recently generated in our lab. Of 118 protein kinase disruption mutants screened,
we identified seven A. fumigatus protein kinases that either significantly increased (n=2) or decreased (n=5)
inflammasome-dependent IL-1β secretion upon disruption. Strikingly, both of the protein kinase disruption
mutants that induced increased IL-1β release encode phospho-relay sensor histidine kinases (phkA and fhk3),
a sub-class of protein kinases that directly sense environmental and intracellular changes and subsequently
activate stress response signaling. The molecular pathways controlled by PhkA and Fhk3 are unknown, as both
HKs are largely uncharacterized. Although a major consequence of HK signaling is activation of stress responses
pathways that upregulate transcription factor activity to respond to environmental stimuli, the downstream
transcriptional effectors for all A. fumigatus HKs remain undescribed. Our work will delineate A. fumigatus
histidine kinase (HK)-dependent mechanisms of host response (Aim 1) and identify A. fumigatus transcriptional
regulators of inflammasome activation (Aim 2). Through completion of the proposed Aims, we will delineate
fungal molecular pathways mediating Aspergillus-induced host response. This work is essential for future
development of novel therapeutic approaches targeted towards activating protection against invasive infections
or mitigating harmful host-response during chronic infections.
我们工作的长期目标是通过以下方式降低曲霉感染相关的发病率和死亡率:
改善宿主与病原体相互作用的结果。烟曲霉是主要的空气传播真菌病原体。
并导致一系列临床综合征,其严重程度取决于宿主免疫状态。
侵袭性肺曲霉病和播散性感染可能发生在严重免疫功能低下的宿主中
在免疫能力强的宿主中,烟曲霉定植的死亡率通常高达 90%。
可导致慢性肺曲霉病 (CPA),这是一种最近定义的诊断临床表现
每年影响超过 160 万人的标准 许多持有 CPA 的人都有潜在的问题。
呼吸系统疾病,例如哮喘或囊性纤维化,这些疾病的存在会进一步加剧
尽管多种病原体相关分子模式(PAMP)驱动宿主识别和
反应是已知的,揭示了新的真菌分子途径,可以作为治疗靶点
增强或掩盖 PAMP 显示和/或生物合成可能证明调节宿主的有用治疗靶点
为了解决这个问题,我们利用了炎症小体(一种多蛋白)的激活。
检测病原微生物以引发炎症反应的细胞内复合物,作为发现的工具
我们已经完成了初步筛选,以改变激活宿主反应的能力。
使用烟曲霉测量巨噬细胞分化的人单核细胞系的 IL-1β 分泌
我们实验室最近筛选了 118 个蛋白激酶破坏突变体,
我们鉴定了七种烟曲霉蛋白激酶,它们要么显着增加(n = 2),要么显着减少(n = 5)
引人注目的是,炎症小体依赖性 IL-1β 分泌受到破坏。
诱导 IL-1β 释放增加的突变体编码磷酸中继传感器组氨酸激酶(phkA 和 fhk3),
蛋白激酶的一个子类,可直接感知环境和细胞内的变化,并随后
PhkA 和 Fhk3 控制的分子途径尚不清楚,因为两者都起作用。
尽管 HK 信号的一个主要后果是应激反应的激活,但 HK 基本上没有特征。
上调转录因子活性以响应环境刺激的途径,下游
所有烟曲霉 HK 的转录效应子仍未被描述,我们的工作将描述烟曲霉。
组氨酸激酶 (HK) 依赖性宿主反应机制(目标 1)并鉴定烟曲霉转录
通过完成拟议的目标,我们将描绘炎症小体激活的调节因子(目标 2)。
介导曲霉诱导的宿主反应的真菌分子途径这项工作对于未来至关重要。
开发新的治疗方法,旨在激活针对侵袭性感染的保护
或减轻慢性感染期间有害的宿主反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jarrod R. Fortwendel其他文献
Jarrod R. Fortwendel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jarrod R. Fortwendel', 18)}}的其他基金
Unlocking the cidal activity of echinocandins against Aspergillus fumigatus
解锁棘白菌素对烟曲霉的杀灭活性
- 批准号:
10378147 - 财政年份:2021
- 资助金额:
$ 23.1万 - 项目类别:
Unlocking the cidal activity of echinocandins against Aspergillus fumigatus
解锁棘白菌素对烟曲霉的杀灭活性
- 批准号:
10179720 - 财政年份:2021
- 资助金额:
$ 23.1万 - 项目类别:
Unlocking the cidal activity of echinocandins against Aspergillus fumigatus
解锁棘白菌素对烟曲霉的杀灭活性
- 批准号:
10590730 - 财政年份:2021
- 资助金额:
$ 23.1万 - 项目类别:
Non-cyp51A-mutation Mediated Triazole Resistance in Aspergillus fumigatus
非 cyp51A 突变介导的烟曲霉三唑耐药性
- 批准号:
10582526 - 财政年份:2020
- 资助金额:
$ 23.1万 - 项目类别:
Non-cyp51A-mutation Mediated Triazole Resistance in Aspergillus fumigatus
非 cyp51A 突变介导的烟曲霉三唑耐药性
- 批准号:
9913275 - 财政年份:2020
- 资助金额:
$ 23.1万 - 项目类别:
Non-cyp51A-mutation Mediated Triazole Resistance in Aspergillus fumigatus
非 cyp51A 突变介导的烟曲霉三唑耐药性
- 批准号:
10358515 - 财政年份:2020
- 资助金额:
$ 23.1万 - 项目类别:
Fungal Ras-mediated invasive growth mechanisms
真菌 Ras 介导的侵袭性生长机制
- 批准号:
9282239 - 财政年份:2014
- 资助金额:
$ 23.1万 - 项目类别:
Fungal Ras-mediated invasive growth mechanisms
真菌 Ras 介导的侵袭性生长机制
- 批准号:
8806512 - 财政年份:2014
- 资助金额:
$ 23.1万 - 项目类别:
Fungal Ras-mediated invasive growth mechanisms
真菌 Ras 介导的侵袭性生长机制
- 批准号:
9205482 - 财政年份:2014
- 资助金额:
$ 23.1万 - 项目类别:
Fungal Ras-mediated invasive growth mechanisms
真菌 Ras 介导的侵袭性生长机制
- 批准号:
8696215 - 财政年份:2014
- 资助金额:
$ 23.1万 - 项目类别:
相似海外基金
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
SARS-CoV-2 免疫失调对抗真菌免疫的影响
- 批准号:
10658355 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别:
Mechanistic Investigation of Gut Mycobiota in the Regulation of Lung Immunity and Disease
肠道菌群调节肺部免疫和疾病的机制研究
- 批准号:
10793853 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别:
Lymph node stromal cells coordinate immune cell environments during Aspergillus fumigatus infection
烟曲霉感染期间淋巴结基质细胞协调免疫细胞环境
- 批准号:
10751936 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别:
Development of a novel broad spectrum antifungal therapeutic targeting Glycosylphosphatidylinositol (GPI) biosynthesis and cell wall biogenesis
开发一种针对糖基磷脂酰肌醇 (GPI) 生物合成和细胞壁生物合成的新型广谱抗真菌治疗药物
- 批准号:
10759723 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别:
Targeted delivery of antifungal drug loaded liposomes to control mucormycosis
靶向递送抗真菌药物脂质体来控制毛霉菌病
- 批准号:
10668509 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别: